Metabolex, Yamanouchi diabetes, obesity deal

Metabolex (Hayward, Calif.) and Yamanouchi (Tokyo, Japan) partnered to develop therapeutics to treat Type II diabetes, insulin resistance, impaired glucose tolerance (IGT) and obesity. The partners wi...